Page last updated: 2024-08-23

paclitaxel and Hydatidiform Mole

paclitaxel has been researched along with Hydatidiform Mole in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ1
Haller, U; Koechli, OR; Perras, JP; Rodriguez, M; Schaer, GN; Schenk, V; Sevin, BU; Steren, A; Untch, M1

Other Studies

2 other study(ies) available for paclitaxel and Hydatidiform Mole

ArticleYear
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms

2007
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms.
    Anti-cancer drugs, 1995, Volume: 6, Issue:1

    Topics: Adenosine Triphosphate; Adult; Antineoplastic Agents; Choriocarcinoma; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Hydatidiform Mole; Paclitaxel; Pregnancy; Trophoblastic Neoplasms; Tumor Cells, Cultured; Uterine Neoplasms; Vincristine

1995